140 results on '"Desaphy, Jean-Francois"'
Search Results
2. How are cell and tissue structure and function influenced by gravity and what are the gravity perception mechanisms?
3. Recommendations of an expert group for the cardiac assessment of non-dystrophic myotonia adult patients treated with mexiletine
4. Preclinical study of the antimyotonic efficacy of safinamide in the myotonic mouse model
5. Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4–1BB: A preclinical study in multiple myeloma
6. Expert opinion on mexiletine treatment in adult patients with myotonic dystrophy
7. How do gravity alterations affect animal and human systems at a cellular/tissue level?
8. Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study
9. Drug repurposing in skeletal muscle ion channelopathies
10. How are cell and tissue structure and function influenced by gravity and what are the gravity perception mechanisms?
11. How to obtain an integrated picture of the molecular networks involved in adaptation to microgravity in different biological systems?
12. Poliprotect ® , a Medical Device Made of Substances, Potently Protects the Human Esophageal Mucosa Challenged by Multiple Agents: Evidence from In Vitro and Ex Vivo Electrophysiological Models.
13. Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders
14. Next-generation sequencing application to investigate skeletal muscle channelopathies in a large cohort of Italian patients
15. Privileged scaffold-based design to identify a novel drug-like 5-HT7 receptor-preferring agonist to target Fragile X syndrome
16. Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo
17. Missense and Non-Missense Lamin A/C Gene Mutations Are Similarly Associated with Major Arrhythmic Cardiac Events: A 20-Year Single-Centre Experience
18. How to obtain an integrated picture of the molecular networks involved in adaptation to microgravity in different biological systems?
19. How are cell and tissue structure and function influenced by gravity and what are the gravity perception mechanisms?
20. How to obtain an integrated picture of the molecular networks involved in adaptation to microgravity in different biological systems?
21. Skeletal muscle ClC-1 chloride channels in health and diseases
22. How do gravity alterations affect animal and human systems at a cellular/tissue level?
23. Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate
24. Effects of Benzothiazolamines on Voltage-Gated Sodium Channels
25. A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions
26. Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity
27. Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin
28. Characterization of Student Drinking Behaviors at the Beginning of the First Academic Year at One University in Southern Italy
29. How do gravity alterations affect animal and human systems at a cellular/tissue level?
30. How do gravity alterations affect animal and human systems at a cellular/tissue level?
31. ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells
32. Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita
33. Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs
34. Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options
35. Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes
36. Molecular Dissection of Lubeluzole Use–Dependent Block of Voltage-Gated Sodium Channels Discloses New Therapeutic Potentials
37. In vivo evaluation of antimyotonic efficacy of β-adrenergic drugs in a rat model of myotonia
38. Taurine and Skeletal Muscle Ion Channels
39. Antioxidant treatment of hindlimb-unloaded mouse counteracts fiber type transition but not atrophy of disused muscles
40. Targeted pharmacotherapy for trafficking defective ClC-1 mutations in myotonia congenita
41. Involvement of voltage-gated sodium channels blockade in the analgesic effects of orphenadrine
42. Effect of microgravity on gene expression in mouse brain
43. Using occurrence data to evaluate extinction reveals a strong resilience of butterflies in a National Park of Southern Europe (Alta Murgia National Park)
44. Ion Channel Pharmacology
45. Buprenorphine may be effective for treatment of paramyotonia congenita
46. Fiber type-related changes in rat skeletal muscle calcium homeostasis during aging and restoration by growth hormone
47. Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in KCNA1 Impairing the Voltage Sensitivity of Kv1.1 Channel
48. Recovery of the soleus muscle after short- and long-term disuse induced by hindlimb unloading: effects on the electrical properties and myosin heavy chain profile
49. Blockade by cAMP of native sodium channels of adult rat skeletal muscle fibers
50. New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.